The Recall Desk
HighCPSC·92125·Announced 1992-08-13

Valumed Diphenhydramine Capsules Recalled for Lack of Child-Resistant Packaging

Moore Medical is recalling 11,000 bottles of Valumed Diphenhydramine Hydrochloride capsules because they lack required child-resistant closures, posing a poisoning risk to children.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (potential death or serious injury to children from ingestion) where the source explicitly states that no injuries or illnesses have been reported, fitting the High severity criteria.

Plain-English summary

Moore Medical Corporation is voluntarily recalling 11,000 bottles of "Valumed" Diphenhydramine Hydrochloride (HCl) 25 milligram capsules. The product, manufactured by Contract Pharmacal, consists of 100-capsule bottles that were distributed without the child-resistant closures required by the Poison Prevention Packaging Act (PPPA).

The recall was initiated because the lack of child-resistant packaging creates a potential toxicity hazard. The source text notes that this medicine could cause serious health problems or death to a child who accidentally swallowed several capsules. Neither the recalling firm nor the Consumer Product Safety Commission (CPSC) is aware of any poisoning incidents resulting from this packaging defect.

The affected bottles were distributed nationwide, including Puerto Rico, from November 1991 to mid-May 1992. Distribution included 171 independent pharmacies, 214 chain drug stores, and 606 professional accounts such as doctors, schools, and nursing homes. Consumers should immediately return the product to the store where it was purchased for a refund.

The recalled product

Product
Over-The-Counter Antihistamine Recalled For Lack Of Child-Resistant Closure
Manufacturer
Moore Medical

Distribution

Distributed nationwide across the United States.